"Ontario" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A province of Canada lying between the provinces of Manitoba and Quebec. Its capital is Toronto. It takes its name from Lake Ontario which is said to represent the Iroquois oniatariio, beautiful lake. (From Webster's New Geographical Dictionary, 1988, p892 & Room, Brewer's Dictionary of Names, 1992, p391)
| Descriptor ID |
D009864
|
| MeSH Number(s) |
Z01.107.567.176.639
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Ontario".
Below are MeSH descriptors whose meaning is more specific than "Ontario".
This graph shows the total number of publications written about "Ontario" by people in this website by year, and whether "Ontario" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 3 | 3 |
| 1996 | 0 | 2 | 2 |
| 1997 | 0 | 1 | 1 |
| 2000 | 0 | 3 | 3 |
| 2004 | 0 | 1 | 1 |
| 2007 | 0 | 2 | 2 |
| 2008 | 0 | 2 | 2 |
| 2009 | 0 | 4 | 4 |
| 2010 | 0 | 3 | 3 |
| 2011 | 0 | 6 | 6 |
| 2012 | 0 | 2 | 2 |
| 2013 | 0 | 4 | 4 |
| 2014 | 0 | 2 | 2 |
| 2015 | 0 | 3 | 3 |
| 2016 | 0 | 4 | 4 |
| 2017 | 0 | 2 | 2 |
| 2018 | 0 | 3 | 3 |
| 2019 | 0 | 5 | 5 |
| 2020 | 0 | 2 | 2 |
| 2021 | 0 | 4 | 4 |
| 2022 | 0 | 2 | 2 |
| 2023 | 0 | 8 | 8 |
| 2024 | 0 | 7 | 7 |
| 2025 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Ontario" by people in Profiles.
-
Real-world healthcare costs for patients treated with chimeric antigen receptor T-cell therapy in Canada. Leuk Lymphoma. 2025 Oct; 66(10):1875-1883.
-
Health Utilities in People with Hepatitis C Virus Infection: A Study Using Real-World Population-Level Data. Med Decis Making. 2025 Apr; 45(3):332-343.
-
Trends in Real-World Clinical Outcomes of Patients with Anaplastic Lymphoma Kinase (ALK) Rearranged Non-Small Cell Lung Cancer (NSCLC) Receiving One or More ALK Tyrosine Kinase Inhibitors (TKIs): A Cohort Study in Ontario, Canada. Curr Oncol. 2024 Dec 27; 32(1).
-
The medical and functional burden of surviving childhood ependymoma: A population-based study in Ontario, Canada. Pediatr Blood Cancer. 2024 Nov; 71(11):e31275.
-
From not knowing, to knowing more needs to be done: health care providers describe the education they need to care for sex trafficked patients. BMC Med Educ. 2024 Jul 31; 24(1):824.
-
Bridging Hepatitis C Care Gaps: A Modeling Approach for Achieving the WHO's Targets in Ontario, Canada. Viruses. 2024 07 31; 16(8).
-
A Unique Comprehensive Model to Screen Newborns for Severe Combined Immunodeficiency-An Ontario Single-Centre Experience Spanning 2013-2023. Genes (Basel). 2024 Jul 15; 15(7).
-
Impact of new direct-acting antiviral therapy on the prevalence and undiagnosed proportion of chronic hepatitis C infection. Liver Int. 2024 Jun; 44(6):1383-1395.
-
Hepatitis C Attributable Healthcare Costs and Mortality among Immigrants: A Population-Based Matched Cohort Study. Can J Gastroenterol Hepatol. 2024; 2024:5573068.
-
Defining pre-emptive living kidney donor transplantation as a quality indicator. Am J Transplant. 2024 Aug; 24(8):1445-1455.